Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Gore launches 3D scanner

This article was originally published in Clinica

Executive Summary

WL Gore & Associates has launched its 3D imaging system, a technology designed to help plan patients' treatment – for vascular abnormalities, for example. It incorporates TeraRecon iNtuition cloud technology, which accesses data stored on the internet. Physicians can "drag and drop" image files to a secure server where they are reviewed by a Gore clinical expert. This decreases turn-around times and reduces the risk of delays while planning cases, Gore believes. The Flagstaff, Arizona-based company is exhibiting the device at the VEITHsymposium, a meeting on vascular and endovascular issues held in New York City on 17-21 November. Another 3D scanner that has been in the news recently is Imaging3's Dominion, which was rejected by the US FDA earlier this month (www.clinica.co.uk, 3 November 2010).

You may also be interested in...



What are the hottest innovations from Israel?

Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.

EuroPCR: St Jude and Philips talk up rival intravascular imaging techs

St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.

EuroPCR: Medtronic's drug-coated balloon keeps rising

A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT096087

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel